Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 2 of 2 drugs
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
Hydrochlorothiazide
(Jamp-losartan Hctz) | [2] Esidrix Esidrix; HYDROCHLOROTHIAZIDE | [1] Hydrochlorothiazide
Hydrochlorothiazide
💬1. Hydrochlorothiazide
| [1] SLC12A3 SLC12A3 💬1. Hydrochlorothiazide
| - | [4] 13 13, 67, 225, 235 💬
| ||||||||||||||||||||||||||||||||||||||||||||
| 2 | Losartan | [3] Cozaar Cozaar; Losartan; LOSARTAN POTASSIUM | [1] Losartan
Losartan
💬2. Losartan
| [1] AGTR1 AGTR1 💬2. Losartan
| [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, A ... | [17] 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬2. Losartan
|